|
The Empire State
Development-Industry Cluster Reports
Biotechnology and Pharmaceuticals
The biotechnology and pharmaceutical industries are among the fastest
growing and most research and development intensive in the United States.
Changes in demographic characteristics have increased the demand for products
that remedy or alleviate medical problems associated with aging, while
rapid advances in knowledge of underlying biological and chemical processes
have resulted in a revolution in the development of medical diagnostics
and treatments.
New York's exceptional research infrastructure has contributed to the
state's strong position in the bio/pharma industry. The State ranks second
in biological research and development expenditures at universities ($1.2
billion in 1997), with three institutions in the top 20 and 11 in the
top 100. Similarly, the State's is a leader in industrial pharmaceutical
research, ranking fourth nationally.
All this has contributed to a large and vital industry within the State.
1997 data shows that more than 720 bio/pharma firms across the New York
State employ more than 40,000 workers. New York's bio/pharma employment
is 9% of the nation's total, significantly more than would be expected
based on the state's population.
The industry is widespread, through virtually every region of New York
State. While about 65% of New York's bio/pharma employment is located
in three regions (the Mid-Hudson, New York City and Long Island), the
1997 data shows that a majority of regions in the State have greater than
expected concentrations of employment compared to the nation, including
the North Country, the Capital Region, the Mid-Hudson Region, Long Island,
Central New York, and Western New York.
The report also includes an analysis of smaller (under 500 employees)
companies in New York State. These smaller companies are often the engines
of growth in industry sectors. ESD's research showed that employment in
these smaller firms was growing at a significantly faster rate than for
the State as a whole, or for the nation. In particular, smaller producers
of pharmaceutical preparations (20% growth from 1994 to 1997), biological
products (69%) and commercial research enterprises (16%) are showing fast
growth in New York State.
Regional Profile
Notable findings relating to regional activity in the bio/pharma
industry as reported in the Empire State Development Industry Cluster
Report.
Capital Region
This region showed the second greatest regional specialization in bio/pharma
of any region in New York State. The region has seen significant growth
in employment in its smaller bio/pharma firms in the areas of pharmaceutical
preparations (45%) and commercial research (111%) from 1994 to 1997. The
State University of New York was one of the top 20 biological research
institutions in the nation, based on 1997 R&D spending. Albany Molecular
Research, Inc., which provides contract research and development, has
been recognized by Inc. magazine for the last two years on its list of
500 fastest growing companies in the United States.
Central New York
This region shows a strong concentration of companies in the bio/pharma
industry, with more than 50% more employees than would be predicted from
its population. Significant growth was seen among smaller companies in
the region among noncommercial research firms. Bristol-Myers Squibb has
more than 1,000 employees in the Central New York area, primarily engaged
in manufacturing pharmaceuticals. The National Science Foundation reported
that the SUNY Health Sciences Center in Syracuse spent nearly $8,000,000
on biological R&D in 1997.
Finger Lakes
The region has more than 1,000 employed in the bio/pharma sector. Significant
growth was seen among smaller companies in the region among manufacturers
of pharmaceutical preparations and laboratory analytical instruments.
Major bio/pharma companies, including Bausch and Lomb, Genencor, and Medeva
Pharmaceuticals have operations in the region. The University of Rochester
ranks among the top fifty universities in the country in biological sciences,
based on the National Science Foundation's rankings of university research
and development expenditures for 1997.
Long Island
Long Island is home to at least 30% of New York's firms in each of biotechnology,
medical devices, pharmaceuticals technology and life-systems technology.
Long Island stands alone as the only region which dominates the state
in all four sub-sectors of bioscience technology. Of the 273 bioscience
technology firms in New York state, Long Island is home to:
- 34% of all Biotechnology firms
- 38% of all Medical devices firms
- 35% of all Pharmaceutical technology firms
- 33% of all Life systems technology firms
40% of the total bioscience technology employment in New York State is on
Long Island. Between 1990 and 1996, Long Island experienced:
- a 68% growth in the absolute number of biotechnology firms located
there
- a 220% increase in the number of local industrial biotechnology jobs
- a doubling of its share of intra-state biotechnology industry employment
from 20% to over 40 percent.
Long Island has added substantially to New York's population of biotechnology
firms and to its total biotechnology employment levels, and it has improved
its position vis-a-vis other regions in the state by both of these measures
(job growth and firm growth). Long Island has also achieved this record
through both sustained local entrepreneurship and internal business growth.
The region is home to a significant number of companies in the industry,
including Del Laboratories, NBTY, Inc., Pall Corporation, and E-Z-EM,
Inc. SUNY- Stony Brook is among the top fifty universities in the country
in biological sciences, based on the National Science Foundation's rankings
of university research and development expenditures for 1997.
Read about ...
LI new $15.7M
STAR Center
Long Island Life Sciences Initiative (LILSI)
The Mid-Hudson Region
The region has more than 8,000 workers in the bio/pharma industry, which
is more than twice as concentrated in the region as it is nationally.
Significant growth was seen among smaller companies in the region from
1994 to 1997 among producers of laboratory apparatus (35% growth) and
commercial research enterprises (13%). The region is home to operations
of major bio/pharma companies such as Bayer Diagnostics, Wyeth-Ayerst,
Novartis, Cultor Food Science, Barr Laboratories, and Regeneron. New York
Medical College, in Valhalla, is among the top hundred universities in
the country in biological sciences, based on the National Science Foundation's
rankings of university research and development expenditures for 1997.
New York City
New York City is home to nearly 200 businesses in the bio/pharma industry,
employting more than 10,000. Major companies, such as Bristol-Myers Squibb
and Pfizer have New York City locations. New York has world class biological
research at centers such as: Rockefeller University, which was second
in the nation in biological R&D spending in 1997, according to the
National Science Foundation. Columbia University, which ranked in the
top 15 in R&D spending according to the NSF Memorial Sloan-Kettering
Cancer Center, which is frequently ranked as the top cancer research and
treatment center in the nation. Cornell University's medical and biological
research programs, which ranked in the top 25 in the country in biological
R&D according to NSF. Mount Sinai School of Medicine, Yeshiva University
and the State University of New York Health Science Center in Brooklyn
also rank among the top centers for biological R&D according to NSF.
The North Country
The North Country showed the greatest specialization in bio/pharma of
any New York region, with more than 1,700 employees. Fast growing sectors
among smaller bio/pharma in the region between 1994 and 1997 were pharmaceutical
preparations (34%) and non-commercial research (20%). Wyeth-Ayerst Division
of American Home Products has two locations in the North Country: Rouses
Point, employing about 1,200, and Chazy, employing about 150. Clarkson
University offers strong training in the biological sciences.
Western New York
Western New York had about 1,400 employees in the Bio/Pharma industry.
Major companies such as Westwood-Squibb Pharmaceuticals and Mentholatum
have operations in the Region. Roswell Park Cancer Institute is one of
the nation's premier centers for cancer research and treatment. SUNY-Buffalo
ranks in the top 40 nationally in biological research, based on NSF data
on 1997 university R&D expenditures.
back to top
|
